Our previous studies revealed that SIC-19 targets SIK2 to induce DNA damage in ovarian cancer cells, so we next investigated the involvement of SIC-19 in triple-negative breast cancer and pancreatic cancer. The gene discussed is SIK2; the disease is pancreatic neoplasm.